Alok Ranjan

Alok Ranjan is a Principal Scientist at Pfizer, with a PhD in Biomedical Sciences, specializing in Cancer Biology. They have over five years of research experience in oncology drug discovery, cancer cell and molecular biology, and in vivo pharmacology studies. Alok has published as lead author in multiple high-impact cancer journals and has received several prestigious awards and research grants as a principal investigator. Previously, they served as a Senior Research Scientist at VCU Massey Cancer Center and a Postdoctoral Fellow at the NIH Clinical Center, where they contributed significantly to the understanding of KRas mutations in cancer. Alok has a strong collaborative background, successfully leading multidisciplinary teams in various research projects.